A decade of running capsule services for national health systems, research programs and hospitals. Every study below links to its source.
Company-reported totals across CorporateHealth International (2015–2025) and GI Digital (since 2020).
Multicentre NHS study sponsored by University Hospitals Coventry and Warwickshire with NIHR funding. It compares AiSPEED™-supported review of colon capsule studies with conventional reading.
Home-delivered colon capsule endoscopy in national screening, with CorporateHealth International delivering and reading capsule studies in several trials.
A national colon capsule service built by NHS boards with the Medtronic and CorporateHealth International partnership.
A SmartBox-supported, remotely supervised home colon capsule service. A small feasibility study of delivery and patient acceptance.
Video capsule endoscopy for lesion localization and diagnosis in patients with severe hematochezia. Led by Dennis M. Jensen, MD, at the CURE Digestive Diseases Research Center at UCLA, with GI Digital supporting the capsule procedures.
Keck Hospital and the Keck School of Medicine of USC worked with GI Digital on a Tele-GI program using the SmartBox and PEARL™.
The island's first capsule endoscopy service, launched in 2024 with GI Digital as general contractor. A second phase added a magnetically controlled gastric capsule.
Previously CE-marked and UKCA-registered as Class I software as a medical device under CorporateHealth International. Not FDA-cleared.
GI Digital uses the quality management system that was certified to ISO 13485 when it was operated by CorporateHealth International.
Grew from an early teleradiology system. Supports remote capsule-video analysis and reporting at Guam Regional Medical City (GRMC) and other hospitals and practices.
A home colon capsule program with the Jewish General Hospital and McGill University in Montréal, based on 5G-SUCCEEDS and adapted for Québec.
Award detailsLogos and program names show that a defined relationship existed. Scope varied by organization and program, and a listing does not imply endorsement or current status.
We'll send our latest capsule evidence summary and the AiSPEED validation brief.